Investors largely expected the FOMC to cut rates by a quarter point.The Fedread more
The lack of clarity surrounding the U.S.-China trade war is what's really hitting global growth, says ex- Deputy Treasury Secretary Sarah Bloom Raskin.World Economyread more
China's economy has long relied on factors such high levels of investments and an expanding labor force for growth. Those growth drivers are running out of steam.China Economyread more
India could benefit from the fallout in the U.S.-China trade war, experts told CNBC — but much-needed reforms on land and labor could prove to be a challenge for companies...Asia Economyread more
New crash tests show the Tesla Model 3 and the Audi e-tron, are among the safest models out on the road. The results bolster the theory electric vehicles may be better...Autosread more
U.S. consumers and growth in sectors such as technology have offset declines in other American industries, says Tom Finke, chairman and CEO of investment management firm...US Economyread more
The FAA administrator's comments come on the eve of his visit to Boeing facilities outside Seattle. While there, he's scheduled to meet with Boeing executives and be briefed...Airlinesread more
Last weekend's attacks on oil facilities — and the spike in crude prices that followed — should show that the world needs to stop relying on oil, says Helen Clark.Energyread more
The photo depicts Canadian leader Justin Trudeau wearing a turban and robe, with dark makeup on his hands, face and neck. Liberal Party spokesman confirms the photo is of...Electionsread more
As the Fed was meeting to consider cutting interest rates, it lost control of the very benchmark rate that it manages.Market Insiderread more
CBS, CNN and other major media companies are starting to pull e-cigarette advertising off their airways, as the death toll from a mysterious vaping-related illness continues...Health and Scienceread more
Edwards Lifesciences shares plunged on Wednesday after the company missed third-quarter sales estimates.
The company posted revenue of $739 million in the third quarter, missing expectations for $750 million, according to a consensus estimate from Thomson Reuters.
Sales of the company's global transcatheter heart valve therapy jumped to $410 million, but were still lower than Wall Street estimates of $425 million.
Transcatheter aortic valve replacement (TAVR) systems, in which a new heart valve is threaded into place via an artery as an alternative to chest-cracking surgery, is one of the most important future growth drivers for the medical device company.
Shares of Edwards Lifesciences shed more than 17 Wednesday, but still held gains of about 19 percent for the year so far. Edwards stock has been a top performer in the S&P 500 in the last few years.
Edwards posted earnings of 68 cents a share, excluding one-time items, in line with expectations.
Separately, Edwards raised its full-year earnings forecast earnings to between $2.82 a share and $2.92 a share. And for the coming quarter, the company expects adjusted earnings of between 67 cents and 77 cents.
One-year performance of Edwards Lifesciences: